Torgny Stigbrand • Jörgen Carlsson
Gregory P. Adams
Editors

2008

Biological Aspects

The last three decades have provided opportunities to explore the potential of treating malignant diseases with antibodies or other targeting molecules labelled with nuclides. While considerable advances have been reported, there is still a significant amount of work left to accomplish before our ambitions can be achieved.